The DOI matches its Crossref record.
Magnesium in the Prophylaxis of Migraine—a Double-Blind, Placebo-Controlled Study
Abstract
The migraine prophylactic effect of 10 mmol magnesium twice-daily has been evaluated in a multicentre, prospective, randomized, double-blind, placebo-controlled study. Patients with two to six migraine attacks per month without aura, and history of migraine of at least 2 years, were included. A 4-week baseline period without medication was followed by 12 weeks of treatment with magnesium or placebo. The primary efficacy end-point was a reduction of at least 50% in intensity or duration of migraine attacks in hours at the end of the 12 weeks of treatment compared to baseline. With a calculated total sample size of 150 patients, an interim analysis was planned after completing treatment of at least 60 patients, which in fact was performed with 69 patients (64F, 5M), aged 18–64 years. Of these, 35 had received magnesium and 34 placebo. The number of responders was 1 in each group (28.6% under magnesium and 29.4% under placebo). As determined in the study protocol, this was a major reason to discontinue the trial. With regard to the number of migraine days or migraine attacks there was no benefit with magnesium compared to placebo. There were no centre-specific differences, and the final assessments of treatment efficacy by the doctor and patient were largely equivocal. With respect to tolerability and safety, 45.7% of patients in the magnesium group reported primarily mild adverse events like soft stool and diarrhoea in contrast to 23.5% in the placebo group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Magnesium in man: implications for health and disease
de Baaij, J. H. F., Hoenderop, J. G. J., & Bindels, R. J. M. (2015) · Physiological Reviews · doi:10.1152/physrev.00012.2014 · Cited by 1,726
EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force
Evers, S., Áfra, J., Frese, A., Goadsby, P. J., Linde, M., May, A., & Sándor, P. S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02748.x · Cited by 892
Self-citationDifferential Effectiveness of Placebo Treatments: A Systematic Review of Migraine Prophylaxis
Meissner, K., Fässler, M., Rücker, G., Kleijnen, J., Hróbjartsson, A., Schneider, A., Antes, G., & Linde, K. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.10391 · Cited by 301
Migraine: Preventive Treatment
Silberstein, S., & Goadsby, P. (2002) · Cephalalgia · doi:10.1046/j.1468-2982.2002.00386.x · Cited by 259
Haag, G., Diener, H.-C., May, A., Meyer, C., Morck, H., Straube, A., Wessely, P., & Evers, S. (2011) · The Journal of Headache and Pain · doi:10.1007/s10194-010-0266-4 · Cited by 78
“domised study [96] which was to include 150 patients, was abandoned following an interim evaluation of 69 patients, as the superiority over placebo treatment, also of a 3-month”
BackgroundSelf-citation
Metadata
- Authors
- Pfaffenrath, V, Wessely, P., Meyer, C., Isler, H., Evers, S., Grotemeyer, K., Taneri, Z., Soyka, D., G”bel, H., & Fischer, M.
- Venue
- Cephalalgia
- Publisher
- SAGE Publications
- Published
- 1996-10
- Volume
- 16
- Issue
- 6
- Pages
- 436-440
- ISSN
- 0333-1024 (ISSN-L)
- 1468-2982
- OpenAlex
- W2049423536
- Cited by
- 204
- References
- 0
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Magnesium in the Prophylaxis of Migraine—a Double-Blind, Placebo-Controlled Study. https://app.cochat.ai/papers/10.1046/j.1468-2982.1996.1606436.x
- The paper
- Pfaffenrath, V, Wessely, P., Meyer, C., Isler, H., Evers, S., Grotemeyer, K., Taneri, Z., Soyka, D., G”bel, H., & Fischer, M. (1996). Magnesium in the Prophylaxis of Migraine—a Double-Blind, Placebo-Controlled Study. Cephalalgia. https://doi.org/10.1046/j.1468-2982.1996.1606436.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.